Healthcare · NSE: DIVISLAB
We don't have a reliable fair-value estimate for Divi's Laboratories Limited yet - our models need more data before we'll publish a number. You can run the valuation with your own assumptions in the Valuation tab, or try the free intrinsic-value calculator.
Divi's Laboratories makes active pharmaceutical ingredients and custom-synthesis products for global drug companies. Its earnings depend on manufacturing efficiency and long-term supply contracts with large pharma clients.
FY26
FY26
FY26
FY26
Over the last 3 years, revenue grew 10.8%/yr and profit grew 12.1%/yr. Over 9 years, revenue grew 11.2%/yr and profit 10.3%/yr.
Every ₹100 of shareholder money earned ₹15.3 in profit last year, vs a sector median of 10.2%.
It holds more cash than debt.
It trades at 115.3x earnings against a sector median of 36.8x.
About ₹16 of every ₹100 of reported profit turned into free cash (median, last 5 years); operating cash flow was positive in 5 of 5 years.
Divi's Laboratories makes active pharmaceutical ingredients and custom-synthesis products for global drug companies. Its earnings depend on manufacturing efficiency and long-term supply contracts with large pharma clients.
Divi's Laboratories Limited operates in the Healthcare sector (Healthcare Services industry) and is listed on the NSE as DIVISLAB.
For FY2017, Divi's Laboratories Limited reported revenue of ₹4,064 Cr and net profit of ₹1,060 Cr. The full multi-year history is in the Financials section above.
In FY2017, Divi's Laboratories Limited recorded earnings per share of ₹40.0 and a return on equity of 19.8%.
Divi's Laboratories Limited reported total debt of ₹36 Cr in FY2017. See the balance-sheet trend in the Financials section for context.
Disclaimer: Intrynsic provides educational and informational analysis only. Fair-value figures are estimates based on stated assumptions- they are not investment advice, research recommendations, or an offer to transact in any security. The models rely on assumptions (discount rates, growth, multiples) that may prove wrong and on past financials, which do not guarantee future results; prices also move on macro factors the models don't capture. Intrynsic is not a SEBI-registered investment adviser or research analyst. Markets carry risk; please do your own research or consult a registered adviser before making investment decisions. Prices shown may be delayed end-of-day values. Terms · Privacy